Emerging concepts and spectrum of renal injury following Intravesical BCG for non-muscle invasive bladder cancer
Open Access
- 6 December 2017
- journal article
- case report
- Published by Springer Nature in BMC Urology
- Vol. 17 (1) , 114
Abstract
Intravesical Bacilli Calmette-Guerin (IVBCG) therapy for non-muscle invasive bladder cancer (NMIBC) has long been in use successfully. Albeit rarely, we still face with its safety concerns more than 25 years on since its approval by US Food and Drug Agency in 1990. Local and systemic infection following intravesical BCG is widely reported as compared to immune mediated local or systemic hypersensitivity reactions involving kidneys; acute kidney injury (AKI) and other renal manifestations are well reported but not of chronic kidney disease (CKD). An interesting case of a female was referred to nephrologists in advanced stages of CKD at an eGFR of 10 ml/min/1.732 following IVBCG for NMIBC. Our patient’s renal function plateaued when IVBCG was held; and worsened again when reinstilled. It introduces the concept of ‘repetitive’ immune mediated renal injury presenting as progressive CKD rather than AKI, as is generally reported. Although response was poor, corticosteroids stopped CKD progression to end stage renal disease. We highlight the need for increased awareness and early recognition of IVBCG renal complications by both urologists and nephrologists in order to prevent progressive and irreversible renal damage. Low incidence of IVBCG renal complications may also be due to under recognition in the era prior to CKD Staging and AKI Network (and AKI e-alerts) that defined AKI as a rise in serum creatinine of ≥26umol/L; hence an unmet need for urgent prospective studies. Major literature review focuses on emerging spectrum of histopathological IVBCG related renal complications and their outcomes.Keywords
This publication has 23 references indexed in Scilit:
- Stage, grade and pathological characteristics of bladder cancer in the UK : B ritish Association of Urological Surgeons ( BAUS ) Urological Tumour RegistryBJU International, 2014
- Upper Tract Urothelial Carcinoma: Current Treatment and OutcomesUrology, 2012
- Acute renal failure due to interstitial nephritis after intravesical instillation of BCGClinical and Experimental Nephrology, 2007
- Nephrotic Syndrome as a Complication of Intravesical BCG Treatment of Transitional Cell Carcinoma of Urinary BladderRenal Failure, 2007
- Acute granulomatous tubulointerstitial nephritis caused by intravesical BCGNephrology Dialysis Transplantation, 2006
- Acute renal failure following intravesical bacille Calmette-Guerin chemotherapy for superficial carcinoma of the bladderNephrology Dialysis Transplantation, 2005
- Spectrum of Bacille Calmette‐Guerin (BCG) Infection after Intravesical BCG ImmunotherapyClinical Infectious Diseases, 2003
- Fatal Systemic Reaction after Multiple Doses of Intravesical Bacillus Calmette-Guérin for PolyposisAnnals of Pharmacotherapy, 2000
- Efficacy and Safety of Bacille Calmette-Guérin Immunotherapy in Superficial Bladder CancerClinical Infectious Diseases, 2000
- Renal Complications of Intravesical Bacillus Calmette-Guérin TherapyAmerican Journal of Nephrology, 1991